Navigation Links
Watson to Host and Webcast Investment Community Meeting at American Urological Association Annual Meeting
Date:4/22/2009

- Company to Highlight Data for its Two Newest Urological Products -

CORONA, Calif., April 22 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a global leader in the development and distribution of pharmaceuticals, announced today that management will host and webcast a meeting for the investment community at the American Urological Association (AUA) Annual Meeting taking place in Chicago, Illinois, April 25-30, 2009.

The company will be hosting the meeting to review new data on its two newest brands, RAPAFLO (silodosin) and GELNIQUE (oxybutynin chloride) Gel 10%, including:

  • Two post-hoc analyses of Phase 3 trials for RAPAFLO(TM) (silodosin): On efficacy, specifically for irritative and obstructive symptoms; and retrograde ejaculation - a harmless side effect of treatment - as an indicator of treatment efficacy. Reviewed by Herbert Lepor, M.D., Department of Urology, New York University School of Medicine, NY
  • The efficacy, safety and tolerability of GELNIQUE(TM) (oxybutynin chloride) Gel 10% versus placebo from Phase 3 trials. Reviewed by Roger R. Dmochowski, M.D., Department of Urologic Surgery, Vanderbilt University School of Medicine, Nashville, TN

The event will be held on Monday, April 27, 2009, from 3:00 p.m. to 5:00 p.m. (CDT) at The Hyatt McCormick in Conference Center Room 12D, adjacent to the McCormick Center, where the AUA meeting is being held. To participate in the event in person, please RSVP to Scott Anderson, Watson Pharmaceuticals, by Friday, April 24, via e-mail, '/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Companies Continue To Add Wellness Programs, Watson Wyatt/National Business Group On Health Survey Finds
2. Mark G. Watson Named Executive Director of Radiological Society of North America
3. Watson Pharmaceuticals and Elan Settle Lawsuit Over Naproxen Sodium
4. Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results; Provides 2009 Outlook
5. Watson Acknowledges Federal Trade Commission Action Regarding AndroGel Patent Settlement
6. Warner Chilcott and Watson Pharmaceuticals Announce Agreements on Loestrin(R) 24 and Femcon(R) Fe Patent Litigation
7. Watson Pharmaceuticals Receives FDA Approval for Mint Coated Nicotine Gum
8. Watson Pharmaceuticals Receives FDA Final Approval for Generic Mircette(R)
9. U.S. Workers Taking Steps to Lower Medical Costs, Watson Wyatt Survey Finds
10. China Shenghuo Announces Additional Roll-Out of 12 Ways Cosmetics Products to Watsons Stores
11. Driving Consumer Engagement Is Focus of Address by Healthfitness Chief Medical Officer at Watson Wyatt Health Care Solutions Event
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... 14, 2014 EurekaMag.com has newly published ... is a contagious liver disease that ranges in ... to a serious, lifelong illness that attacks the liver. ... have chronic Hepatitis C virus infection of which approximately ... research category covers all studies on Hepatitis C ...
(Date:7/14/2014)... Wa (PRWEB) July 14, 2014 ... Violet Protocol book review recently updated by ... consists of a wide range of simple ... of endometriosis including:, ... meat and dairy products ,     Increasing ...
(Date:7/14/2014)... 2014 Carepoint has been designed ... by combining an intuitive interface for recording, sending, ... service tracking and reporting features. , Hall mc ... teamed up with Rebecca de Witte to create ... organizations. , Carepoint provides seamless, real-time ...
(Date:7/14/2014)... Columbus, OH (PRWEB) July 14, 2014 ... as litigation continues against seven different pelvic mesh manufacturers ... Virginia notes Wright & Schulte LLC. The federal complaints ... Inc. (MDL No. 2327), American Medical Systems (MDL No. ... of June 16th, there are 58,262 Vaginal Mesh lawsuit ...
(Date:7/14/2014)... (PRWEB) July 14, 2014 In ... carriers emphasized lower-cost narrow-network products, accountable care organizations ... chose coverage based on price, rather than on ... from seeking care from out-of-network providers. “Using ... Narrow Networks and Exchange Products,” the July ...
Breaking Medicine News(10 mins):Health News:EurekaMag.com Publishes 64,900 New Studies on Hepatitis C 2Health News:Endometriosis Bible and Violet Protocol Book Review Exposes Zoe Brown's Endometriosis Treatment Guide – Vkool.com 2Health News:Endometriosis Bible and Violet Protocol Book Review Exposes Zoe Brown's Endometriosis Treatment Guide – Vkool.com 3Health News:Home Health Care Professional and Marketing Firm Team Up to Create New Homecare Communication App 2Health News:Nearly 60,000 Vaginal Mesh Lawsuit Claims Filed Against Seven Different Pelvic Mesh Manufacturers 2Health News:Nearly 60,000 Vaginal Mesh Lawsuit Claims Filed Against Seven Different Pelvic Mesh Manufacturers 3Health News:Nearly 60,000 Vaginal Mesh Lawsuit Claims Filed Against Seven Different Pelvic Mesh Manufacturers 4Health News:Nearly 60,000 Vaginal Mesh Lawsuit Claims Filed Against Seven Different Pelvic Mesh Manufacturers 5Health News:Milliman, FAIR Health Executives to Discuss Data-Based Rate Setting for Out-of-Network Providers in Atlantic Information Services Webinar 2
... drug-eluting stents (DES), could be responsible for causing life-threatening// clots ... Centre has warned. ,Angioplasty is a medical ... or blocked blood vessels of the heart. ... vessel is a common procedure, with over 30,000 cases performed ...
... United States, FDA and Centers for Disease Control are trying ... and peanut butter. Around one hundred cases of salmonella infection ... a group of bacteria that is responsible for causing fever, ... and 600 deaths are reported every year. Generally these infections ...
... effect on weakening of muscles and ligaments in women’s body. ... ,According to Dr. Sandler, the levels of hormones oestrogen and ... When the level of oestrogen decreases during the middle of ... and ligaments and women are prone to back pain during ...
... Organization (PAHO) are working with health authorities in Paraguay ... has affected a// number of communities throughout the nation ... America. ,PAHO officials warn that the entire ... prepare for what promises to be a "difficult year" ...
... cells transplanted into rats’ damaged spinal cords have survived, ... own spinal cord cells in a Johns Hopkins laboratory, ... nerve repair. ,A report on the experiments ... and “establishes a new doctrine for regenerative neuroscience,” says ...
... accurate way to predict the risk of developing cardiovascular ... issue of JAMA. ,"In the decade between ... hypertension (high blood pressure), smoking, diabetes and hyperlipidemia (high ... and coined the term coronary risk factors," according to ...
Cached Medicine News:Health News:PAHO Urges Readiness for Dengue Outbreaks in 2007 2Health News:Human Stem Cell Transplants Repair Rat Spinal Cords 2Health News:New Cardiovascular Risk Prediction Models Developed for Women 2
(Date:7/14/2014)... 2014  Mylan Inc. (NASDAQ: MYL ) today ... Abbott (NYSE: ABT ) ... developed markets specialty and branded generics business ("the Assets") in ... will receive 105 million shares of the combined company worth ... on Friday, July 11, 2014, representing an approximately 21% ownership ...
(Date:7/11/2014)... CHAPEL HILL, N.C. , July 11, 2014 ... component of pharmaceutical marketing and, consequently, organizations are ... specifically for patients. As part of ... learned it,s important to educate, communicate and engage ... from disease awareness to patient empowerment. By mapping ...
(Date:7/11/2014)... Research and Markets  has announced the ... report to their offering. ... a hollow needle commonly used with a syringe to ... fluids from it. A hypodermic needle is used for ... cannot be ingested. Hypodermic needles are broadly classified into ...
Breaking Medicine Technology:Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 2Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 3Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 4Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 5Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 6Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 7Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 8Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 9Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 10Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 11New Study Uses Six-Step Patient Journey as Framework for Consumer-Focused Marketing Opportunities 2Global Hypodermic Needles Market 2014-2018: Key Vendors are Becton, Dickinson and Co, Covidien, Retractable Technologies and Terumo Corp. 2Global Hypodermic Needles Market 2014-2018: Key Vendors are Becton, Dickinson and Co, Covidien, Retractable Technologies and Terumo Corp. 3
... spine can happen for any number of reasons, whether it,s ... old age, or blunt injury. Unfortunately, people who have experienced ... back braces, reduced mobility, and elongated periods of pain and ... patients are able to restore proper function to the spine ...
... 17, 2011 Zen Holding Corp. (Symbol: ZNHL) today ... name change to Millennium HealthCare Inc.  The Company will ... change as well. About Zen Holding Corp. ... company that operates thru its wholly-owned subsidiaries Greenleaf Management ...
Cached Medicine Technology:Dr. Seyed M. Rezaian's Spinal Fixator a Revolutionary Invention for Healing Injuries of the Thoracolumbar Spine 2Zen Holding Corp. Changes Name to Millennium HealthCare Inc. 2
... This microtome is the most convenient ... research and in industrial laboratories. Specimen rise ... setting from 0.5 to 12 microns in ... all MNL Freezing Stages.,Other Associated Products, ...
... The Starter Package is a ... laboratory. The package includes the Vibratome ... blocks, v-block adapter, specimen mounts w/1/2" ... for ease in all of your ...
... is a solid solution for ... package includes the Vibratome Plus, ... blocks, v-block adapter, specimen mounts ... stage assembly for ease in ...
... The Vibratome 1500 Sectioning System provides a ... animal, or plant tissues. The 1500 ... sectioning without freezing or embedding. The ... the destruction of enzyme activities, and other ...
Medicine Products: